Childhood Ependymoma — Trials

Childhood Ependymoma — Trials · CancerIndex

Clinical trials

Registered studies

33 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–33 of 33 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03210714	Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)	active not recruiting	Phase 2	20	National Cancer Institute (NCI)NIH	2	Sep 22, 2026	clinicaltrials
NCT05857969	Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling	recruiting	Phase 1	65	Florida International UniversityOTHER	1	Aug 26, 2026	clinicaltrials
NCT02359565	Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma	active not recruiting	Phase 1	71	National Cancer Institute (NCI)NIH	2	Jul 20, 2026	clinicaltrials

Data updated 4 days agoSource updated Sep 22, 2026source: clinicaltrials